Corebridge Financial’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,841	Closed	-$54.3K	–	872
2025 Q1	$54.3K	Sell	9,841 -146	-1%	-$806	﹤0.01%	2706
2024 Q4	$57.4K	Sell	9,987 -754	-7%	-$4.34K	﹤0.01%	2791
2024 Q3	$111K	Sell	10,741 -66	-0.6%	-$684	﹤0.01%	2566
2024 Q2	$140K	Buy	+10,807	New	+$140K	﹤0.01%	2408